HK1045150A1 - 類鴉片化合物 - Google Patents

類鴉片化合物

Info

Publication number
HK1045150A1
HK1045150A1 HK02104802.8A HK02104802A HK1045150A1 HK 1045150 A1 HK1045150 A1 HK 1045150A1 HK 02104802 A HK02104802 A HK 02104802A HK 1045150 A1 HK1045150 A1 HK 1045150A1
Authority
HK
Hong Kong
Prior art keywords
diarrhoea
gastritis
customarily
analgesics
epilepsy
Prior art date
Application number
HK02104802.8A
Other languages
English (en)
Inventor
Clarke Stephen
Dondio Giulio
Francesco Raveglia Luca
Ronzoni Silvano
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Farm Spa filed Critical Smithkline Beecham Plc
Publication of HK1045150A1 publication Critical patent/HK1045150A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK02104802.8A 1999-04-20 2002-06-27 類鴉片化合物 HK1045150A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000816A IT1312083B1 (it) 1999-04-20 1999-04-20 Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico.
PCT/GB2000/001516 WO2000063210A1 (en) 1999-04-20 2000-04-19 Morphinoid compounds

Publications (1)

Publication Number Publication Date
HK1045150A1 true HK1045150A1 (zh) 2002-11-15

Family

ID=11382772

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104802.8A HK1045150A1 (zh) 1999-04-20 2002-06-27 類鴉片化合物

Country Status (10)

Country Link
US (1) US6696457B1 (zh)
EP (1) EP1171441B1 (zh)
JP (1) JP2002542247A (zh)
AT (1) ATE268773T1 (zh)
AU (1) AU4584100A (zh)
CO (1) CO5170445A1 (zh)
DE (1) DE60011417D1 (zh)
HK (1) HK1045150A1 (zh)
IT (1) IT1312083B1 (zh)
WO (1) WO2000063210A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067950A1 (en) * 1998-07-27 2004-04-08 Schering-Plough Corporation High affinity ligands for nociceptin receptor ORL-1
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CA2894963A1 (en) * 2012-12-14 2014-06-19 Purdue Pharma L.P. Pyridonemorphinan analogs and biological activity on opioid receptors
US8987287B2 (en) * 2012-12-14 2015-03-24 Purdue Pharma L.P. Spirocyclic morphinans and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270612B (it) * 1994-07-14 1997-05-07 Smithkline Beecham Farma Derivati eterociclo-condensatori di morfinoidi
EP0880526B1 (en) * 1996-01-10 2002-12-18 GlaxoSmithKline S.p.A. Heterocycle-condensed morphinoid derivatives (ii)

Also Published As

Publication number Publication date
IT1312083B1 (it) 2002-04-04
ATE268773T1 (de) 2004-06-15
US6696457B1 (en) 2004-02-24
DE60011417D1 (de) 2004-07-15
WO2000063210A1 (en) 2000-10-26
EP1171441A1 (en) 2002-01-16
EP1171441B1 (en) 2004-06-09
ITMI990816A1 (it) 2000-10-20
CO5170445A1 (es) 2002-06-27
AU4584100A (en) 2000-11-02
JP2002542247A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
IL157563A0 (en) Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers
GB9903762D0 (en) Organic compounds
GB0225474D0 (en) Therapeutic agents
GB0223038D0 (en) Therapeutic compounds
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
GB0318447D0 (en) Therapeutic agents
EP2269610A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
HK1083624A1 (en) Hydroxyethylamine derivatives for the treatment ofalzheimer's disease
EP2767291A3 (en) Treatment of glycogen storage disease type II
MXPA05009694A (es) Metodos para mejorar la calidad de la piel.
SG151336A1 (en) 1,3,4-oxadiazol-2-ones as ppar delta
EP1780197A4 (en) 5-SUBSTITUTED-2-PHENYLAMINE BENZAMIDE AS MEK INHIBITOR
IL178167A0 (en) 1,3,4-oxadiazol-2-ones as ppar delta modulators
UA92164C2 (ru) Соединения, пригодные для угнетения снк1
WO2006021002A3 (en) Compounds useful for inhibiting chk1
WO2008157787A3 (en) Hydroxylated tolans and related compounds in the treatment of cancer
ATE437855T1 (de) (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit
HK1045150A1 (zh) 類鴉片化合物
ZA200609220B (en) Method of treating dry eye disorders and uveitis
ATE464048T1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
HK1129071A1 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
GB0522908D0 (en) Therapeutic agents
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice
GB0229022D0 (en) Organic Compounds
WO2005009982A3 (en) Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators